Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.
1d
Zacks.com on MSNAMGN's Q4 Earnings Beat, Obesity Candidate Under FDA Clinical HoldAmgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...
Three people with a muscle-destroying disease destined to worsen got a little stronger when an implanted device zapped their ...
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human ...
(Reuters) – The U.S. Food and Drug Administration approved Amgen’s combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation. Amgen’s Lumakras in combination ...
Jan 16 (Reuters) - The U.S. Food and Drug Administration approved Amgen's (AMGN.O), opens new tab combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.
Lindsay Arnold posted about her breast augmentation surgery on social media on Jan. 15. Athena Sobhan is a Digital News Writer at PEOPLE since 2024. Her work has previously appeared in POPSUGAR ...
“Dancing With the Stars” alum Lindsay Arnold is showing off her breast implants after undergoing augmentation surgery — all to silence the haters. “Post-surgery Linsday is a sight to se ...
The former Bravo star has been candid about her plastic surgery procedures in the past, including getting a nose job, having breast implants and dabbling with Botox and filler. And now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results